The Role of Protein Tyrosine Phosphatase SHP-1 in the Regulation of IFN-γ Signaling in Neural Cells

Journal of Immunology

Volumn 157, Issue 11, 1996, Pages 5139-5144

  Massa, Paul T ^a   Wu, Charlene ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; GAMMA INTERFERON; GAMMA INTERFERON ACTIVATION FACTOR; HLA ANTIGEN CLASS 1; INTERFERON REGULATORY FACTOR 1; INTERFERON STIMULATED GENE FACTOR 3; IRF1 PROTEIN, MOUSE; PHOSPHOPROTEIN; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE SHP 1; PTPN6 PROTEIN, MOUSE; SIGNAL PEPTIDE; SRC HOMOLOGY 2 (SH2) DOMAIN CONTAINING PHOSPHATASES; SRC HOMOLOGY-2 (SH2) DOMAIN-CONTAINING PHOSPHATASES; TRANSCRIPTION FACTOR; VANADIC ACID;

ANIMAL; ARTICLE; ASTROCYTE; CELL CULTURE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; MUTATION; NUCLEOTIDE SEQUENCE; OLIGONUCLEOTIDE PROBE; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ASTROCYTES; BASE SEQUENCE; CELLS, CULTURED; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; INTERFERON REGULATORY FACTOR-1; INTERFERON TYPE II; INTERFERON-STIMULATED GENE FACTOR 3; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MUTATION; OLIGONUCLEOTIDE PROBES; PHOSPHOPROTEINS; PROTEIN-TYROSINE-PHOSPHATASE; SHP1 PROTEIN TYROSINE PHOSPHATASE; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; VANADATES;

EID: 0030457034     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Darnell, J. E., Jr., I. M. Kerr, and G. R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415.
2. Ihle, J. N., B. A. Witthuhn, F. W. Quelle, K. Yamamoto, and O. Silvennoinen. 1995. Signaling through the hematopoietic cytokine receptors. Annu. Rev. Immunol. 13:369.
3. Ihle, J. N., and I. M. Kerr. 1995. Jaks and Stats in signaling by the cytokine receptor superfamily. Trends Genet. 11:69.
4. Ihle, J. N. 1996. STATs: signal transducers and activators of transcription. Cell 84:331.
5. Kimura, T., K. Nakayama, J. Penninger, M. Kitagawa, H. Harada, T. Matsuyama, N. Tanaka, R. Kamijo, J. Vilcek, T. W. Mak, and T. Taniguchi. 1994. Involvement of the IRF-1 transcription factor in antiviral responses to interferons. Science 264:1921.
6. Meraz, M. A., J. M. White, K. C. F. Sheehan, E. A. Bach, S. J. Rodig, A. S. Dighe, D. H. Kaplan, J. K. Riley, A. C. Greenland, D. Campbell, K. Carver-Moore, R. N. DuBois, R. Clark, M. Aguet, and R. K. Schreiber. 1996. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signalling pathway. Cell 84:431.
7. Briscoe, J., D. Guschin, N. C. Rogers, D. Watling, M. Muller, F. Horn, P. Heinrich, G. R. Stark, and I. M. Kerr. 1996. JAKs, STATs, and signal transduction in response to the interferons and other cytokines. Philos. Trans. R. Soc. Lond-Biol. Sci. 351:167.
8. Larner, A. C., and D. S. Finbloom. 1995. Protein cyrosine phosphorylation as a mechanism which regulates cytokine activation of early response genes. Biochim. Biophys. Acta 1266:278.
9. Igarashi, K., G. Garotta, L. Ozmen, A. Ziemiecki, A. F. Wilks, A. G. Harpur, A. C. Larner, and D. S. Finbloom. 1994. Interferon-γ induces tyrosine phosphorylation of interferon-γ receptor and regulated association of protein tryrosine kinases, Jak1 and Jak2. with its receptor. J. Biol. Chem. 269:14333.
10. Shuai, K., C. M. Horvath, L. H. T. Huang, S. Qureshi, D. Cowburn, and J. E. Damell, Jr. 1994. Interferon activation of the transcription factor Statp91 involves dimerization through SH2-phosphotyrosyl peptide interactions. Cell 76:821.
11. Lamb, P., J. Haslam, K. Kessler, M. Seidel, R. B. Stein, and J. Rosen. 1994. Rapid activation of the interferon-γ signal transduction pathway by inhibitors of tyrosine phosphatases. J. Interferon Res. 14:365.
12. Tourkine, N., C. Schindler, M. Larose, and L.-M. Houdebine. 1995. Activation of STAT factors by prolactin, interferon-γ, growth hormones, and a tyrosine phosphatase inhibitor in rabbit primary mammary epithelial cells. J. Biol. Chem. 270: 20952.
13. Neel, B. G. 1993. Structure and function of SH2-domain containing tyrosine phosphatases. Semin. Cell Biol. 4:419.
14. Adachi, M., E. H. Fischer, J. Ihle, K. Imai, F. Jirik, B. Neel, T. Pawson, S.-H. Shen, M. Thomas, A. Ullrich, and Z. Zhao. 1996. Mammalian SH2-containing protein tyrosine phosphatase. Cell 85:15.
15. David, M., H. E. Chen, S. Goelz, A. C. Lamer, and B. G. Neel. 1995. Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1. Mol. Cell. Biol. 15:7050.
16. Klingmuller, U., U. Lorenz, L. C. Cantley, B. G. Neel, and H. F. Lodish. 1995. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell 80:729.
17. Yi, T., A. L.-F. Mui, G. Krystal, and J. N. Ihle. 1993. Hematopoietic cell phosphatase associates with the interleukin-3 (II-3) receptor β chain and down-regulates II-3-induced tyrosine phosphorylation and mitogenesis. Mol. Cell. Biol. 13: 7577.
18. Cyster, J. G., and C. C. Goodnow. 1995. Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection. Immunity 2:13.
19. Yi, T., J. Zhang, O. Miura, and J. N. Ihle. 1995. Hematopietic cell phosphatase associates with erythropoietin (Epo) receptor after Epo-induced receptor tyrosine phosporylation: identification of potential binding sites. Blood 85:87.
20. Shultz, L. D., P. A. Schweitzer, T. V. Rajan, T. Yi, J. N. Ihle, R. J. Matthews, M. L. Thomas, and D. R. Beier. 1993. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 73:1445.
21. Mauerhoff, T., R. Pujol-Borrell, R. Mirakian, and G. F. Bottazzo. 1988. Differential expression and regulation of major histocompatibility complex (MHC) products in neural and glial cells of the human fetal brain. J. Neuroimmunol. 18:271.
22. Schijns, V. E., R. Van der Neut, B. L. Haagmans, D. R. Bar, H. Schellekens, and M. C. Horzinek. 1991. Tumour necrosis factor-alpha, interferon-gamma and interferon-beta exert antiviral activity in nervous tissue cells. J. Gen. Virol. 72:809.
23. Massa, P. T., K. Ozato, and D. E. McFarlin. 1993. Cell type-specific regulation of major histocompatibility complex (MHC) class I gene expression in astrocytes, oligodendrocytes, and neurons. Glia 8:201.
24. Ward, L. A., and P. T. Massa. 1995. Neuron-specific regulation of major histocompatibility complex class I, interferon-β, and anti-viral state genes. J. Neuroimmunol. 58:145.
25. Drew, P. D., M. Lonergan, M. E. Goldstein, L. A. Lampson, K. Ozato, and D. E. McFarlin. 1993. Regulation of MHC class I and β2-microglobulin gene expression in human neuronal cells. J. Immunol. 150:3300.
26. Massa, P. T., and H. Wu. 1995. Interferon regulatory factor element and interferon regulatory factor 1 in the induction of major histocompatibility complex class I genes in neural cells. J. Interferon Cytokine Res. 15:799.
27. Benveniste, E. N., and D. J. Benos. 1995. TNF-α- and IFN-γ-mediated signal transduction pathways: effects on glial cell gene expression and function. FASEB J. 9:1577.
28. Lampson, L. A. 1987. Molecular basis of immune response to neural antigens. Trends Neurosci. 10:211.
29. Joly, E., L. Mucke, and M. B. A. Oldstone. 1991. Viral persistence in neurons explained by lack of major histocompatibility class I expression. Science 253: 1283.
30. Panek, R. B., Y. J. Lee, and E. N. Benveniste. 1995. TGF-β suppression of IFN-γ-induced class II MHC gene expression does not involve inhibition of phosphorylation of JAK1, JAK2, or signal transducers and activators of transcription, or modification of IFN-γ-enhanced factor X expression. J. Immunol. 154:610.
31. Lu, H.-T., J. L. Riley, G. T. Babcock, M. Huston, G. R. Stark, J. M. Boss, and R. M. Ransohoff. 1995. Interferon (IFN) β acts downstream of IFN-γ-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-γ. J. Exp. Med. 182:1517.
32. Massa, P. T., and H. L. Wu. 1995. Interferon regulatory factor element and interferon regulatory factor 1 in the induction of major histocompatibility complex class I genes in neural cells. J. Interferon Cytokine Res. 15:799.
33. Springer, T. A. 1980. Cell surface differentiation in the mouse. In Monoclonal Antibodies. R. H. Kennett, T. J. McKern, and K. B. Bechtol. eds. Plenum Press, NY, pp. 185-217.
34. Lee, K. A., A. Bindereif, and M. R. Green. 1988. A small-scale procedure for preparation of nuclear extracts that support efficient transcription and pre-mRNA splicing. Gene Anal. Tech. 5:22.
35. Massa, P. T., S. Hirschfeld, B.-Z. Levi, L. A. Quigley, K. Ozato, and D. E. McFarlin. 1992. Expression of major histocompatibility complex (MHC) class I genes in astrocytes correlates with the presence of nuclear factors that bind to constitutive and inducible enhancers. J. Neuroimmunol. 41:35.
36. Harada, H., E. Takahashi, S. Itoh, K. Harada, T. A. Hori, and T. Taniguchi. 1994. Structure and regulation of the human interferon regulatory factor 1 (IRF-1) and IRF-2 genes: implications for a gene network in the interferon system. Mol. Cell. Biol. 14:1500.
37. Flanagan, J. R., M. Murata, P. A. Burke, Y. Shirayoshi, E. Appella, P. A. Sharp, and K. Ozato. 1991. Negative regulation of the major histocompatibility complex class I promoter in embryonal carcinoma cells. Proc. Natl. Acad. Sci. USA 88: 3145.
38. Fried, M., and D. M. Crothers. 1981. Equilibria and kinetics of lac repressor-operator interactions by polyacrylamide gel electrophoresis. Nucleic Acids Res. 9:6505.
39. Garner, M., and A. Rezvin. 1981. A gel electrophoresis method for quantifying the binding of proteins to specific DNA regions: applications to components of the E. coli lactose operon regulatory system. Nucleic Acids Res. 9:3047.
40. Brady-Kalnay, S. M., D. L. Rimm, and N. K. Tonks. 1995. Receptor protein tyrosine phosphatase PTPmu associates with cadherins and catenins in vivo. J. Cell Biol. 130:977.
41. Sims, S. H., Y. Cha, M. F. Romine, P.-Q. Gao, K. Gottlieb, and A. B. Deisseroth. 1993. A novel interferon-inducible domain: structural and functional analysis of the human interferon regulatory factor 1 gene promoter. Mol. Cell Biol. 13:690.
42. Rein, T., M. Muller, and H. Zorbas. 1994. In vivo footprinting of the IRF-1 promoter: inducible occupation of a GAS element next to a persistent structural alteration of the DNA. Nucleic Acids Res. 22:3033.
43. Durbin, J. E., R. Hackenmiller, M. C. Simon, and D. E. Levy. 1996. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84:443.
44. Reis, L. F., H. Harada, J. D. Wolchok, T. Taniguchi, and J. Vilcek. 1992. Critical role of a common transcription factor, IRF-1, in the regulation of IFN-beta and IFN-inducible genes. EMBO J. 11:185.
45. Lim, S. P., and K. M. Hui. 1994. Characterization of a novel IRF-1-deficient mutant cell line. Immunogenetics 39:168.
46. Yi, T., J. L. Cleveland, and J. N. Ihle. 1992. Protein tyrosine phosphatase containing SH2 domains: characterization, preferential expression in hematopoietic cells, and localization to human chromosome 12p12-p13. Mol. Cell. Biol. 12:836.
47. Ihle, J. N. 1996. Janus kinases in cytokine signalling. Philos. Trans. R. Soc. Lond-Biol. Sci. 351:159.
48. Li, X., S. Leung, S. Qureshi, J. E. Darnell, Jr., and G. R. Stark. 1996. Formation of STAT1-STAT2 heterodimers and their role in the activation of IRF-1 gene transcription by interferon-α. J. Biol. Chem. 271:5790.
49. Look, D. C., M. R. Pelletier, R. M. Tidwell, W. T. Roswit, and M. J. Holtzman. 1995. Stat1 depends on transcriptional synergy with Sp1. J. Biol. Chem. 270: 30264.
50. Dhib-Jalbut, S. S., and E. P. Cowan. 1993. Direct evidence that interferon-β mediates enhanced HLA-class I expression in measles virus-infected cells. J. Immunol. 151:6248.
51. Lieberman, A. P., P. M. Pitha, H. S. Shin, and M. L. Shin. 1989. Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc. Natl. Acad. Sci. USA 86:6348.
52. Drew, P. D., G. Franzoso, K. G. Becker, V. Bours, L. M. Carlson, U. Siebenlist, and K. Ozato. 1995. NFκB and interferon regulatory factor 1 physically interact and synergistically induce major histcompatibility class I gene expression. J. Interferon Cytokine Res. 15:1037.
53. Shrikant, P., I. Y. Chung, M. E. Ballestas, and E. N. Benveniste. 1994. Regulation of intercellular adhesion molecule-1 gene expression by tumor necrosis factor-alpha, interleukin-1 beta, and interferon-gamma in astrocytes. J. Neuroimmunol. 51:209.
54. Cannella, B., A. H. Cross, and C. S. Raine. 1991. Adhesion-related molecules in the central nervous system: upregulation correlates with inflammatory cell influx during relapsing experimental autoimmune encephalomyelitis. Lab. Invest. 65: 23.
55. Traugott, U. 1987. Multiple sclerosis: relevance of class I and class II MHC-expressing cells to lesion development. J. Neuroimmunol. 16:283.
56. Traugott, U., and P. Lebon. 1988. Multiple sclerosis: involvement of interferons in lesion pathogenesis. Ann. Neurol. 24:243.
57. Rall, G. F., L. Mucke, and M. B. A. Oldstone. 1995. Consequences of cytotoxic T lymphocyte interactions with major histocompatibility complex class I-expressing neurons in vivo. J. Exp. Med. 182:1201.
58. Ransohoff, R. M., and M. L. Estes. 1991. Astrocyte expression of major histocompatibility complex gene products in multiple sclerosis brain tissue obtained by stereotactic biopsy. Arch. Neurol. 48:1244.
59. Ransohoff, R. M., C. Devajyothi, M. L. Estes, G. Babcock, R. A. Rudick, E. M. Frohman, and B. P. Barna. 1991. Interferon-beta specifically inhibits interferon-gamma-induced class II major histocompatibility complex gene transcription in a human astrocytoma cell line. J. Neuroimmunol. 33:103.